£520.00

It has never been this cheap. We have no record of a lower price.

£520 today · cheaper than every other day in the last 3 months

2023-2028 US Bile Duct Cancer Treatment Market Outlook

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 82 days · 82 data points (no recent data)

Historical
Generating forecast…
£520.00 £494.00 £504.40 £514.80 £525.20 £535.60 £546.00 12 August 2026 01 September 2026 21 September 2026 11 October 2026 01 November 2026
View at Amazon ↗

Price data last checked 9 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 82 days • 1 price levels

Days at Price
82 days 0 21 41 62 82 £520 Days at Price

Price Analysis

Most common price: £520 (82 days, 100.0%)

Price range: £520 - £520

Price levels: 1 different prices over 82 days

Description

This comprehensive study provides a detailed outlook for bile duct cancer (cholangiocarcinoma) treatments across the United States from 2023 to 2028. It offers specific latent demand estimates, also known as potential industry earnings (P.I.E.), across approximately 12,600 cities. By reporting the percent share of each city relative to its state and the nation, this data provides comparative benchmarks for market analysis. This statistical approach supports strategic planning for distribution and sales force management within the pharmaceutical and medical sectors.

Key Features

Provides latent demand outlook for bile duct cancer treatments in the United States from 2023 to 2028.

Includes potential industry earnings (P.I.E.) estimates for approximately 12,600 cities.

Reports city percent share relative to both state and national totals for comparative benchmarking.

Supports distribution and sales force strategies through detailed statistical data.

Covers cholangiocarcinoma treatment market trends across various states and cities.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
26 October 2022
Listed Since
09 November 2022

Similar Products You Might Like

Bile Duct Cancer Treatment Outlook in India 2023-2028
99% match

Bile Duct Cancer Treatment Outlook in India 2023-2028

£515.00 04 Nov 2026
The 2023-2028 Outlook for Bile Duct Cancer (Cholangiocarcinoma) Treatments in China
99% match

The 2023-2028 Outlook for Bile Duct Cancer (Cholangiocarcinoma) Treatments in China

£495.00 09 Nov 2026
The 2023-2028 Outlook for Bile Duct Cancer (Cholangiocarcinoma) Treatments in Japan
99% match

The 2023-2028 Outlook for Bile Duct Cancer (Cholangiocarcinoma) Treatments in Japan

£495.00 30 Oct 2026
The 2023-2028 World Outlook for Bile Duct Cancer (Cholangiocarcinoma) Treatments
99% match

The 2023-2028 World Outlook for Bile Duct Cancer (Cholangiocarcinoma) Treatments

Price unavailable
Bile Duct Cancer Treatment Outlook 2023-2028 - US Zip Codes
98% match

Bile Duct Cancer Treatment Outlook 2023-2028 - US Zip Codes

£490.00 05 Nov 2026
Basal Cell Carcinoma Treatments Outlook 2023-2028 Report
97% match

Basal Cell Carcinoma Treatments Outlook 2023-2028 Report

£520.00 03 Nov 2026
Basal Cell Carcinoma Surgery Outlook 2023-2028 Report
97% match

Basal Cell Carcinoma Surgery Outlook 2023-2028 Report

£520.00 01 Nov 2026
US Liver Cancer Drug Outlook 2016-2021 Econometric Study
97% match

US Liver Cancer Drug Outlook 2016-2021 Econometric Study

£595.00 01 Nov 2026
Basal Cell Carcinoma Treatment Outlook in India 2023-2028
97% match

Basal Cell Carcinoma Treatment Outlook in India 2023-2028

£515.00 12 Sep 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
97% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States

£520.00 30 Sep 2026
US Cancer Supportive Care Outlook 2023-2028 Study Report
97% match

US Cancer Supportive Care Outlook 2023-2028 Study Report

£520.00 07 Nov 2026
Targeted Therapy Liver Cancer Drugs Outlook 2023-2028
97% match

Targeted Therapy Liver Cancer Drugs Outlook 2023-2028

£520.00 06 Nov 2026
Basal Cell Carcinoma Surgeries in India Outlook 2023-2028
97% match

Basal Cell Carcinoma Surgeries in India Outlook 2023-2028

£515.00 02 Nov 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India
97% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India

£515.00 30 Sep 2026
Targeted Therapy Liver Cancer Drugs India Outlook 2023-2028
97% match

Targeted Therapy Liver Cancer Drugs India Outlook 2023-2028

£515.00 07 Nov 2026
Cancer Supportive Care Drugs Outlook 2023-2028 Report
97% match

Cancer Supportive Care Drugs Outlook 2023-2028 Report

£520.00 06 Nov 2026
2023-2028 US Cancer Screening Outlook - Market Study
97% match

2023-2028 US Cancer Screening Outlook - Market Study

£520.00 05 Nov 2026
India Cancer Supportive Care Drugs Outlook 2023-2028
97% match

India Cancer Supportive Care Drugs Outlook 2023-2028

£515.00 06 Nov 2026
The 2016-2021 Outlook for Liver Cancer Drugs in Japan
97% match

The 2016-2021 Outlook for Liver Cancer Drugs in Japan

£595.00 27 Aug 2026
The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
97% match

The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States

£595.00 04 Nov 2026
The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in Greater China
97% match

The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in Greater China

£595.00 27 Oct 2026
US Cancer Diagnostics Lab Test Outlook 2023-2028 Study
97% match

US Cancer Diagnostics Lab Test Outlook 2023-2028 Study

£520.00 06 Nov 2026
The 2016-2021 Outlook for Pancreatic Cancer Drugs in the United States
97% match

The 2016-2021 Outlook for Pancreatic Cancer Drugs in the United States

£595.00 08 Nov 2026
The 2016-2021 World Outlook for Non-Small Cell Lung Cancer Therapeutics
97% match

The 2016-2021 World Outlook for Non-Small Cell Lung Cancer Therapeutics

£995.00 02 Nov 2026